Mymetics Corp (MYMX)

[extrinsic55]

Aeglea BioTherapeutics Shares Spike After Merger, New Funding
Shares of Aeglea BioTherapeutics spiked after the company said it had struck a deal to merge with privately owned Spyre Therapeutics and reached a deal to raise about $210 million through a private placement.
The stock jumped 531% to over 67 cents a share in morning trading. Over the past 12 months, the stock is now up about 4%.
Aeglea said it has agreed to sell Series A non-voting convertible preferred stock to a group of institutional investors led by Fairmount Funds Management. Aeglea expects to raise about $210 million, which will be used to advance its newly acquired portfolio of products from Spyre.
The infusion is expected to fund operations into 2026.
The company is working on advancing treatments for inflammatory bowel disease.